Advanced Search Results For "SU(COVID-19)"
Your filters
Changes Afoot: 2022 Outlook for Pharma and its People.
Publication Type: Periodical
Source(s): Pharmaceutical Technology Europe; Jan2022, Vol. 34 Issue 1, p10-13, 4p
Abstract: The article provides an outlook for the pharmaceutical industry for 2022. By the end of the year, the reformation of the pharmaceutical legislation will be implemented in Europe. It mentions the impact of supply chain disruptions on drug supply in 2021...
Global Vaccine Access Challenges FDA and Industry.
Publication Type: Periodical
Source(s): Pharmaceutical Technology; Feb2022, Vol. 46 Issue 2, p14-15, 2p
Abstract: The article discusses the challenge posed by the necessity for global COVID-19 vaccine access to the U.S. Food and Drug Administration (FDA) and the pharmaceutical industry in 2022. The importance of expanded vaccination in Africa and other regions was...
Spotlight on Pediatric COVID-19 Vaccines: After multiple approvals and emergency use authorizations, it's time to take stock of the state of pediatric COVID-19 vaccines.
Publication Type: Periodical
Source(s): Drug Topics; Dec2022, Vol. 166 Issue 12, p38-39, 2p
Abstract: The article discusses myths and facts on pediatric coronavirus disease 2019 (COVID-19) vaccines as of December 2022. Topics covered include such misconceptions as children and teenagers not getting infected with severe acute respiratory syndrome (SARS)...
Global Vaccine Access Challenges Regulatory Agencies and Industry.
Publication Type: Periodical
Source(s): Pharmaceutical Executive Global Digest; Feb2022, Vol. 42 Issue 2, p5-5, 1p
FDA, Industry Prepare for Transition From COVID-Driven EUAs: Changes likely with looming end to emergency use authorizations.
Publication Type: Periodical
Source(s): Pharmaceutical Executive Global Digest. May2022, Vol. 42 Issue 5, p6-6. 1p.
ASIAN BIOTECH CLINICAL TRIAL DEMAND MOVES TO THE WEST.
Publication Type: Academic Journal
Source(s): Applied Clinical Trials; Jan/Feb2022, Vol. 31 Issue 1/2, p10-11, 2p
Abstract: An interview with AUM Biosciences chief executive officer (CEO) Harish Dave is presented. He explains the firm's goal of developing affordable cancer treatments and agile clinical trials. He talks about the challenges they faced during their conduct of...
Know Your Winter Respiratory Illness.
Publication Type: Periodical
Source(s): Drug Topics; Jan2023, Vol. 167 Issue 1, p18-19, 2p
Abstract: The article states that influenza and respiratory syncytial virus are spreading uncontrollably in the United States. It shares a reference guide for each of these respiratory conditions. It mentions that influenza has symptoms such as headache, cough, ...
Patients With Cancer Have Unique Considerations When Receiving Vaccines.
Publication Type: Periodical
Source(s): Pharmacy Times. Nov2021, Vol. 87 Issue 11, p25-25. 1p.
Abstract: Notably, the investigators said that they focused on patients with solid tumors, such as breast or gastrointestinal cancer, and excluded patients receiving immunotherapy.1 In the second study, published in JAMA Oncology, investigators found that the ty...
Addressing Racial and Ethnic Disparities in Women's Mental Health Care.
Publication Type: Academic Journal
Source(s): Psychiatric Times; Jul2023, Vol. 40 Issue 7, p28-31, 4p
Abstract: An interview with Dr. Wilsa M. S. Charles Malveaux is presented. Malveaux discusses the most significant racial/ethnic disparities in women's mental health care, the factors that contribute to or perpetuate these disparities, and how disparities affect...
Open Payments 2022: An analysis of industry payments to urologists.
Publication Type: Periodical
Source(s): Urology Times; Aug2023, Vol. 51 Issue 8, p21-29, 6p
Abstract: The article reviews information, trends and analysis of industry payments from device manufacturers to urologists reported in 2022 under the Affordable Care Act's Physician Sunshine Act section. Data shows payments to physicians by specialty and manufa...